According to MarkNtel Advisors’ research report titled “Global Liquid Biopsy Market Analysis, 2020”, the Global Liquid Biopsy market is anticipated to grow at a CAGR of around 26% during 2021-26F.

1. Global Liquid Biopsy
Market Analysis, 2021
marknteladvisors.com

2. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 2
Document Outline
Sample Pages
Global Liquid Biopsy Market Analysis, 2021
19
Research Process & Methodology
Key questions answered in the report, Research process, Primary Research, Secondary Research,
Respondent Profile
26
Table of Content
Market Segmentation, Scope of Work
02
Commercials 92
Company Profile
About the company
94
Contact Details 96

3. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 3
Market Segmentation
Global Liquid Biopsy Market Segmentation
• Blood
• Urine
• Saliva
• CerebroSpinal
Fluid
By Work Process By Products
• Test /Services
• Kits and
Consumables
• Instruments
By Sample Type
• RUO
• Clinical
By Usage
• Sample
Preparation
• Library
Preparation
• Sequencing
• Data Analysis
• PCR
• NGS
• FISH
• Other
Technologies
By Technology
By Circulating
Biomarkers
• Circulating
Tumor Cells
• Cell-free DNA
• Circulating Cell-
Free RNA
• Exosomes and
Extracellular
Vesicles
• Others
By Clinical
Application
• Treatment
Monitoring
• Prognosis and
Recurrence
Monitoring
• Treatment
Selection
• Diagnosis and
Screening
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Colorectal
Cancer
• Melanoma
• Other Cancers
• Non-Oncology
Disorders
By Disease Type
By Companies
• Bio-Rad Laboratories
• Biocept Inc
• Abcodia Ltd
• Chronix Biomedical
• Epic Sciences Inc
• Hoffmann-La Roche AG
• Cynvenio Biosystems, Inc.
• Guardant Health, Inc
• Illumina, Inc.
• NeoGenomics
Laboratories, Inc
• Menarini Silicon
Biosystems, Inc.
• Qiagen N.V.
• Thermo Fisher Scientific
• Personal Genome
Diagnostics, Inc.
• Qiagen N.V.
By Region
• North America
o The US
o Canada
o Mexico
• South America
o Brazil
o Others
• Europe
o The UK
o Germany
o France
o Italy
o Spain
• Middle East & Africa
o UAE
o Saudi Arabia
o South Africa
• Asia-Pacific
o China
o India
o Japan
o South Korea
o South East Asia
Total Pages in Report: 370+
Month of Publishing: December, 2020

4. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 4
Table of Content (1/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
1. Introduction
1.1. Product Definition
1.2. Research Process
1.3. Market Segmentation
1.4. Assumptions
2. Preface
3. Executive Summary
4. Impact of COVID-19 on Global Liquid Biopsy Market
5. Global Liquid Biopsy Market Venture Capital Ecosystem
5.1. Financing By Key Investors
5.2. Financing Recipient Wise Details
6. Global Liquid Biopsy Market Outlook, 2016-2026F
6.1. Market Size & Analysis
6.1.1. Revenues
6.2. Market Share & Analysis
6.2.1. By Work Process
6.2.1.1. Sample Preparation
6.2.1.2. Library Preparation
6.2.1.3. Sequencing
6.2.1.4. Data Analysis

5. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 5
Table of Content (2/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
6.2.2. By Technology
6.2.2.1. PCR
6.2.2.1.1. RT-PCR
6.2.2.1.2. dPCR
6.2.2.1.3. Multiplex PCR
6.2.2.1.4. Others
6.2.2.2. NGS
6.2.2.3. FISH
6.2.2.4. Other Technologies
6.2.3. By Usage
6.2.3.1. RUO
6.2.3.2. Clinical
6.2.4. By Sample Type
6.2.4.1. Blood
6.2.4.2. Urine
6.2.4.3. Saliva
6.2.4.4. CerebroSpinal Fluid
6.2.5. By Products
6.2.5.1. Test /Services
6.2.5.2. Kits and Consumables

6. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 6
Table of Content (3/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
6.2.5.3. Instruments
6.2.6. By Circulating Biomarkers
6.2.6.1. Circulating Tumor Cells
6.2.6.2. Cell-free DNA
6.2.6.3. Circulating Cell-Free RNA
6.2.6.4. Exosomes and Extracellular Vesicles
6.2.6.5. Others
6.2.7. By Disease Type
6.2.7.1. Lung Cancer
6.2.7.2. Breast Cancer
6.2.7.3. Prostate Cancer
6.2.7.4. Colorectal Cancer
6.2.7.5. Melanoma
6.2.7.6. Other Cancers
6.2.7.7. Non-Oncology Disorders
6.2.8. By Clinical Application
6.2.8.1. Treatment Monitoring
6.2.8.2. Prognosis and Recurrence Monitoring
6.2.8.3. Treatment Selection
6.2.8.4. Diagnosis and Screening

7. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 7
Table of Content (4/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
6.2.9.1. North America
6.2.9.2. South America
6.2.9.3. Europe
6.2.9.4. Middle East & Africa
6.2.9.5. Asia-Pacific
6.2.10. By Company
6.2.10.1. Competition Characteristics
6.2.10.2. Market Share & Analysis (2018, 2019, 2020)
6.2.10.3. Competitive Matrix
7. North America Liquid Biopsy Market Outlook, 2016-2026F
7.1. Market Size & Analysis
7.1.1. Revenues
7.2. Market Share & Analysis
7.2.1. By Technology
7.2.2. By Usage
7.2.3. By Sample Type
7.2.4. By Products
7.2.5. By Circulating Biomarkers
7.2.6. By Disease Type
7.2.7. By Clinical Applications

8. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 8
Table of Content (5/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
7.2.8. By Country
7.2.8.1. The US Liquid Biopsy Market Outlook, 2016-2026F
7.2.8.1.1. Market Size & Analysis
7.2.8.1.1.1. Revenues
7.2.8.1.2. Market Share & Analysis
7.2.8.1.2.1. By Circulating Biomarkers
7.2.8.1.2.2. By Disease Type
7.2.8.1.2.3. By Clinical Applications
7.2.8.2. Canada Liquid Biopsy Market Outlook, 2016-2026F
7.2.8.2.1. Market Size & Analysis
7.2.8.2.1.1. Revenues
7.2.8.2.2. Market Share & Analysis
7.2.8.2.2.1. By Circulating Biomarkers
7.2.8.2.2.2. By Disease Type
7.2.8.2.2.3. By Clinical Applications
7.2.8.3. Mexico Liquid Biopsy Market Outlook, 2016-2026F
7.2.8.3.1. Market Size & Analysis
7.2.8.3.1.1. Revenues
7.2.8.3.2. Market Share & Analysis
7.2.8.3.2.1. By Circulating Biomarkers

9. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 9
Table of Content (6/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
7.2.8.3.2.2. By Disease Type
7.2.8.3.2.3. By Clinical Applications
8. South America Liquid Biopsy Market Outlook, 2016-2026F
8.1. Market Size & Analysis
8.1.1. Revenues
8.2. Market Share & Analysis
8.2.1. By Technology
8.2.2. By Usage
8.2.3. By Sample Type
8.2.4. By Products
8.2.5. By Circulating Biomarkers
8.2.6. By Disease Type
8.2.7. By Clinical Applications
8.2.8. By Country
8.2.8.1. Brazil Liquid Biopsy Market Outlook, 2016-2026F
8.2.8.1.1. Market Size & Analysis
8.2.8.1.1.1. Revenues
8.2.8.1.2. Market Share & Analysis
8.2.8.1.2.1. By Circulating Biomarkers
8.2.8.1.2.2. By Disease Type

10. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 10
Table of Content (7/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
8.2.8.1.2.3. By Clinical Applications
9. Europe Liquid Biopsy Market Outlook, 2016-2026F
9.1. Market Size & Analysis
9.1.1. Revenues
9.2. Market Share & Analysis
9.2.1. By Technology
9.2.2. By Usage
9.2.3. By Sample Type
9.2.4. By Products
9.2.5. By Circulating Biomarkers
9.2.6. By Disease Type
9.2.7. By Clinical Applications
9.2.8. By Country
9.2.8.1. Germany Liquid Biopsy Market Outlook, 2016-2026F
9.2.8.1.1. Market Size & Analysis
9.2.8.1.1.1. Revenues
9.2.8.1.2. Market Share & Analysis
9.2.8.1.2.1. By Circulating Biomarkers
9.2.8.1.2.2. By Disease Type
9.2.8.1.2.3. By Clinical Applications

11. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 11
Table of Content (8/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
9.2.8.2. France Liquid Biopsy Market Outlook, 2016-2026F
9.2.8.2.1. Market Size & Analysis
9.2.8.2.1.1. Revenues
9.2.8.2.2. Market Share & Analysis
9.2.8.2.2.1. By Circulating Biomarkers
9.2.8.2.2.2. By Disease Type
9.2.8.2.2.3. By Clinical Applications
9.2.8.3. The United Kingdom Liquid Biopsy Market Outlook, 2016-2026F
9.2.8.3.1. Market Size & Analysis
9.2.8.3.1.1. Revenues
9.2.8.3.2. Market Share & Analysis
9.2.8.3.2.1. By Circulating Biomarkers
9.2.8.3.2.2. By Disease Type
9.2.8.3.2.3. By Clinical Applications
9.2.8.4. Italy Liquid Biopsy Market Outlook, 2016-2026F
9.2.8.2. France Liquid Biopsy Market Outlook, 2016-2026F
9.2.8.2.1. Market Size & Analysis
9.2.8.2.1.1. Revenues
9.2.8.2.2. Market Share & Analysis
9.2.8.2.2.1. By Circulating Biomarkers

12. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 12
Table of Content (9/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
9.2.8.4.1. Market Size & Analysis
9.2.8.4.1.1. Revenues
9.2.8.4.2. Market Share & Analysis
9.2.8.4.2.1. By Circulating Biomarkers
9.2.8.4.2.2. By Disease Type
9.2.8.4.2.3. By Clinical Applications
9.2.8.5. Spain Liquid Biopsy Market Outlook, 2016-2026F
9.2.8.5.1. Market Size & Analysis
9.2.8.5.1.1. Revenues
9.2.8.5.2. Market Share & Analysis
9.2.8.5.2.1. By Circulating Biomarkers
9.2.8.5.2.2. By Disease Type
9.2.8.5.2.3. By Clinical Applications
10. Middle East & Africa Liquid Biopsy Market Outlook, 2016-2026F
10.1.Market Size & Analysis
10.1.1. Revenues
10.2.Market Share & Analysis
10.2.1. By Technology
10.2.2. By Usage
10.2.3. By Sample Type

13. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 13
Table of Content (10/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
10.2.4. By Products
10.2.5. By Circulating Biomarkers
10.2.6. By Disease Type
10.2.7. By Clinical Applications
10.2.8. By Country
10.2.8.1. Saudi Arabia Liquid Biopsy Market Outlook, 2016-2026F
10.2.8.1.1. Market Size & Analysis
10.2.8.1.1.1. Revenues
10.2.8.1.2. Market Share & Analysis
10.2.8.1.2.1. By Circulating Biomarkers
10.2.8.1.2.2. By Disease Type
10.2.8.1.2.3. By Clinical Applications
10.2.8.2. UAE Liquid Biopsy Market Outlook, 2016-2026F
10.2.8.2.1. Market Size & Analysis
10.2.8.2.1.1. Revenues
10.2.8.2.2. Market Share & Analysis
10.2.8.2.2.1. By Circulating Biomarkers
10.2.8.2.2.2. By Disease Type
10.2.8.2.2.3. By Clinical Applications
10.2.8.3. South Africa Liquid Biopsy Market Outlook, 2016-2026F

14. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 14
Table of Content (11/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
10.2.8.3.1. Market Size & Analysis
10.2.8.3.1.1. Revenues
10.2.8.3.2. Market Share & Analysis
10.2.8.3.2.1. By Circulating Biomarkers
10.2.8.3.2.2. By Disease Type
10.2.8.3.2.3. By Clinical Applications
11. Asia-Pacific Liquid Biopsy Market Outlook, 2016-2026F
11.1.Market Size & Analysis
11.1.1. Revenues
11.2.Market Share & Analysis
11.2.1. By Technology
11.2.2. By Usage
11.2.3. By Sample Type
11.2.4. By Products
11.2.5. By Circulating Biomarkers
11.2.6. By Disease Type
11.2.7. By Clinical Applications
11.2.8. By Country
11.2.8.1. China Liquid Biopsy Market Outlook, 2016-2026F
11.2.8.1.1. Market Size & Analysis

15. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 15
Table of Content (12/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
11.2.8.1.1.1. Revenues
11.2.8.1.2. Market Share & Analysis
11.2.8.1.2.1. By Circulating Biomarkers
11.2.8.1.2.2. By Disease Type
11.2.8.1.2.3. By Clinical Applications
11.2.8.2. India Liquid Biopsy Market Outlook, 2016-2026F
11.2.8.2.1. Market Size & Analysis
11.2.8.2.1.1. Revenues
11.2.8.2.2. Market Share & Analysis
11.2.8.2.2.1. By Circulating Biomarkers
11.2.8.2.2.2. By Disease Type
11.2.8.2.2.3. By Clinical Applications
11.2.8.3. Japan Liquid Biopsy Market Outlook, 2016-2026F
11.2.8.3.1. Market Size & Analysis
11.2.8.3.1.1. Revenues
11.2.8.3.2. Market Share & Analysis
11.2.8.3.2.1. By Circulating Biomarkers
11.2.8.3.2.2. By Disease Type
11.2.8.3.2.3. By Clinical Applications
11.2.8.4. South Korea Liquid Biopsy Market Outlook, 2016-2026F

16. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 16
Table of Content (13/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
11.2.8.4.1. Market Size & Analysis
11.2.8.4.1.1. Revenues
11.2.8.4.2. Market Share & Analysis
11.2.8.4.2.1. By Circulating Biomarkers
11.2.8.4.2.2. By Disease Type
11.2.8.4.2.3. By Clinical Applications
11.2.8.5. South East Asia Liquid Biopsy Market Outlook, 2016-2026F
11.2.8.5.1. Market Size & Analysis
11.2.8.5.1.1. Revenues
11.2.8.5.2. Market Share & Analysis
11.2.8.5.2.1. By Circulating Biomarkers
11.2.8.5.2.2. By Disease Type
11.2.8.5.2.3. By Clinical Applications
12. Global Liquid Biopsy Market List of Biopsies Approved by The Governments
13. Global Liquid Biopsy Market Policies, Regulations, Product Standards
13.1.The United States
13.2.European Union
14. Global Liquid Biopsy Market Intellectual Property Rights Insights
14.1.Patent Portfolio of Leading Players
14.2.Patent Filings, Registrations and Expiration

17. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 17
Table of Content (14/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
15. Global Liquid Biopsy Market Trends & Insights
16. Global Liquid Biopsy Market Dynamics
16.1.Growth Drivers
16.2.Challenges
16.3.Impact Analysis
17. Global Liquid Biopsy Market Hotspot & Opportunities
18. Competition Outlook
18.1.Competition Matrix
18.1.1. Product/ Solution Portfolio
18.1.2. Target Markets
18.1.3. Target End Users
18.1.4. Research & Development
18.1.5. Strategic Alliances
18.1.6. Strategic Initiatives
18.2.Competitor Capability Matrix
18.2.1. By Technology
18.2.2. By Sample Type
18.2.3. By Biomarker
18.2.4. By Application
18.3.Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials,
Strategic Alliances/ Partnerships, Future Plans)

18. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 18
Table of Content (15/15)
Historical Year: (2016-19)
Base Year: 2020
Forecast Year: (2021-26)
Table of Content
18.3.1. Bio-Rad Laboratories
18.3.2. Biocept Inc
18.3.3. Abcodia Ltd
18.3.4. Chronix Biomedical
18.3.5. Epic Sciences Inc
18.3.6. Hoffmann-La Roche AG
18.3.7. Cynvenio Biosystems, Inc.
18.3.8. Guardant Health, Inc
18.3.9. Illumina, Inc.
18.3.10. NeoGenomics Laboratories, Inc.
18.3.11. Menarini Silicon Biosystems, Inc.
18.3.12. Qiagen N.V.
18.3.13. Thermo Fisher Scientific
18.3.14. Personal Genome Diagnostics, Inc.
18.3.15. Qiagen N.V.
19. Disclaimer

19. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.
Global Liquid Biopsy Market Outlook, 2016-2026F

20. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 20
Global Liquid Biopsy Market Analysis, 2016-2026F
Source: MarkNtel Advisors, E: Estimated, F: Forecast
Figure XX: Global Liquid Biopsy Industry Revenues (USD Million), 2016- 2026F
Market at a Glance
2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F 2026F
CAGR
CAGR
Revenue: XX% Revenue: XX%
• The global liquid biopsy market has witnessed significant growth, attributing to the increasing demand for less invasive biopsies and
other monitoring approaches while treating cancer patients. Liquid biopsies had also been instrumental in other settings including early
screening, treatment decision, redesigning treatment approaches, and prenatal screening. Further, the increasing utilization of the non-
invasive biopsy procedures in the developed and the developing countries is the key driver for the growth of the global liquid biopsy
market. The emergence of SARS-CoV-2 in Wuhan, China, has resulted in a pandemic, thereby negatively affecting the healthcare
continuum worldwide. The liquid biopsy testing industry had also been negatively impacted by the pandemic. The consolidated revenues
of the key players had been dropped significantly, owing to an underlying reduction in cancer testing volume. With the exponentially

21. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 21
Global Liquid Biopsy Market, By Work Process
Figure XX: Global Liquid Biopsy Market Revenue Share (%) 2020 & 2026, By Work Process
Sample Preparation
Library Preparation
Sequencing
Data Analysis
2020 2026F
Market Description
Source: MarkNtel Advisors
• The global liquid biopsy market (by work process) comprises four main steps comprise Sample preparation, Library preparation,
Sequencing, Data analysis and management. The sample preparation or pre-analytical, phase of liquid biopsy workflow includes all the
steps prior to analysis, such as specimen collection, stabilization, transport, enrichment, processing, and isolation and quality assessment
of the analyte. The purpose of the sample preparation workflow is to maintain the integrity of the sample following blood draw and
prepare it for analysis. The pre-analytical phase is the most important part of liquid biopsy workflows as most of the errors happened
during this phase. These errors can negatively affect data quality outcomes in the later stages and can result in incorrect treatment
decisions.

22. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 22
Global Liquid Biopsy Market, By Work Process
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Sample Preparation X X X X X X X X X X X
Library Preparation X X X X X X X X X X X
Sequencing X X X X X X X X X X X
Data Analysis X X X X X X X X X X X
Table XX: Global Liquid Biopsy Market Revenue (USD Million), By Work Process, 2016- 2026F
Source: MarkNtel Advisors

23. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 23
Global Liquid Biopsy Market, Growth Analysis By Work Process
CAGR 2021-2026F
Market
Share
(%)
High
High
Low
XX Growth, XX Market Share
1. Sample Preparation
Market Share Analysis
• The sample preparation work process is gaining
traction in the worldwide market. The changing
individuals lifestyle is surging the prevalence of
developing cancer, which, in turn, the requirement
for sample preparation is increasing over the last
couple of years.
• The other factors such as surging research and
development, government initiatives towards
surging medical tourism, increasing number of
healthcare units couple with mounting number of
patients;’ footfall is expected to drive the demand
for sample preparation work process across the
globe by 2026.
Source: MarkNtel Advisors,
0%
50%
100%
0% 13% 25%
XXX
Figure XX: Global Liquid Biopsy Market Opportunity Metrix, By Revenues By Work Process, 2021-26
XXX
XXX
XXX

24. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 24
Global Liquid Biopsy Market, By Usage
Market Size, By Usage (USD Million)
Source: MarkNtel Advisors
RUO Clinical
Inner Circle: 2020; Outer Circle: 2026
Market Share, By Usage
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
RUO X X X X X X X X X X X
Clinical X X X X X X X X X X X
Figure XX: Global Liquid Biopsy Market Revenue Share (%) 2020 & 2026, & Market Revenue (USD Million), By Usage, 2016- 2026F
• The global liquid biopsy market (by Usage), is presently dominated by RUO applications, with a value of USDX million, as of 2020.
However, clinical applications are expected to have the highest CAGR, growing at X% during the forecast period, 2021-2026. Identification
of biomarkers has been a prerequisite for the success of treatment and recurrence monitoring and targeted therapies decision making
processes and understand mechanisms of resistance. While the clinical utility of biomarkers has been a long-established fact for the
screening and diagnosis of patients, research into developing targeted therapeutics has emerged as a rapidly growing industry for liquid
Clinical Applications would Grow at a Maximum CAGR

25. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 25
0%
50%
100%
0% 13% 25%
Global Liquid Biopsy Market, Growth Analysis By Usage
CAGR 2021-2026F
Market
Share
(%)
High
High
Low
XX Growth, XX Market Share
1. Clinical
Market Share Analysis
• The aged population has a high risk of developing
cancer owing to genetic factors, obesity, etc. In
2019, around 0.7 billion individuals were aged 65
or above which is expected to reach about 1
billion by 2030. With the mounting number of
elder individuals, the demand for liquid biopsy in
clinical usage across the globe.
• Growing co-development of drug-diagnostic pairs
coupled up with increasing implementation of
biopsies in standard treatment decision and
recurrence monitoring practices is further driving
the usage of liquid biopsy for clinical practices.
Source: MarkNtel Advisors,
XXX
XXX
Figure XX: Global Liquid Biopsy Market Opportunity Metrix, By Revenues By Usage, 2021-26

26. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 26
Global Liquid Biopsy Market, By Sample Type
Market Size, By Sample Type (USD Million)
Source: MarkNtel Advisors
Blood Urine Saliva CerebroSpinal Fluid
Inner Circle: 2020; Outer Circle: 2026
Market Share, By Sample Type
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Blood
X X X X X X X X X X X
Urine
X X X X X X X X X X X
Saliva
X X X X X X X X X X X
CerebroSpinal
Fluid
X X X X X X X X X X X
Figure XX: Global Liquid Biopsy Market Revenue Share (%) 2020 & 2026, & Market Revenue (USD Million), By Sample Type, 2016- 2026F
• The global liquid biopsy market (by sample type) is currently dominated by blood samples. In terms of the type of samples used during
the test, the market has been segmented into blood samples and non-blood samples. The contribution of blood samples was valued at
USDX million in 2020 and is expected to reach USDX million by 2026, witnessing a CAGR of X% during the forecast period. The growth can
be accounted to the potential of blood samples, such as plasma and serum, continuing to be the choice of sample from patients due to
standardized norms.
Market Insights

27. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 27
Global Liquid Biopsy Market, By Competition- Competitor’s Market Share
Bio-Rad Lab Biocept Abcodia Chronix Biomedical Epic Sciences F.Hoffmann-La Roche
Cynvenio Guardant Illumina NeoGenomics Menarini Silicon Qiagen
ThermoFisher Personal Genome Qiagen Others
Table XX: Global Liquid Biopsy Market Revenue Share, By Competitors, 2018, 2019 & 2020
 Inner Circle: 2018
 Middle Circle: 2019
 Outer Circle: 2020

28. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved.
North America Liquid Biopsy Market Outlook, 2016-2026F

29. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 29
North America Liquid Biopsy Market Analysis, 2016-2026F
Source: MarkNtel Advisors, E: Estimated, F: Forecast
Figure XX: North America Liquid Biopsy Industry Revenues (USD Million), 2016- 2026F
Market at a Glance
2016 2017 2018 2019 2020 2021F 2022F 2023F 2024F 2025F 2026F
CAGR
CAGR
Revenue: XX% Revenue: XX%
• North America liquid biopsy market is foreseen to be majorly driven by technological developments in the field of genomics and
molecular diagnostics. The advanced research and development in the field of molecular diagnostics have significantly aided in
understanding the biology of various types of cancer, such as lung cancer, breast cancer, and colorectal cancer.
• The rising prevalence of aforementioned cancers in the US has significantly elevated the requirement of novel diagnostic technologies
with ability to aid in the monitory of the treatment. Further, the growing prominence for non-invasive diagnostic technologies has
significantly elevated the demand for liquid biopsy tests

30. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 30
North America Liquid Biopsy Market, By Technology
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
PCR X X X X X X X X X X X
NGS X X X X X X X X X X X
FISH X X X X X X X X X X X
Other Technologies X X X X X X X X X X X
Table XX: North America Liquid Biopsy Market Revenue (USD Million), By Technology, 2016- 2026F
Source: MarkNtel Advisors

31. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 31
North America Liquid Biopsy Market, By Disease Type
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Lung Cancer X X X X X X X X X X X
Breast Cancer X X X X X X X X X X X
Prostate Cancer X X X X X X X X X X X
Colorectal Cancer X X X X X X X X X X X
Melanoma X X X X X X X X X X X
Other Cancers X X X X X X X X X X X
Non-Oncology
Disorders
X X X X X X X X X X X
Table XX: North America Liquid Biopsy Market Revenue (USD Million), By Disease Type, 2016- 2026F
Source: MarkNtel Advisors

32. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 32
North America Liquid Biopsy Market, By Clinical Applications
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Treatment
Monitoring
X X X X X X X X X X X
Prognosis and
Recurrence
Monitoring
X X X X X X X X X X X
Treatment Selection X X X X X X X X X X X
Diagnosis and
Screening
X X X X X X X X X X X
Table XX: North America Liquid Biopsy Market Revenue (USD Million), By Clinical Applications, 2016- 2026F
Source: MarkNtel Advisors

33. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 33
Document Outline
Sample Pages
Global Liquid Biopsy Market Analysis, 2021
19
Research Process & Methodology
Key questions answered in the report, Research process, Primary Research, Secondary Research,
Respondent Profile
26
Table of Content
Market Segmentation, Scope of Work
02
Commercials 92
Company Profile
About the company
94
Contact Details 96

34. Copyright 2021. Reproduction is forbidden unless authorized. All rights reserved. 34
+1 (604) 800-2671, +91 8719999009
sales@marknteladvisors.com